WASHINGTON: COVID-19 may do more than trigger an infection with SARS-CoV-2. A new study has found that the illness can be accompanied by the reactivation of dormant viruses already present in the ...

WASHINGTON: The vaccine technology that became globally familiar during the COVID-19 pandemic has reached another major milestone: the US Food and Drug Administration (FDA) has approved MFLUSIVA, ...